Nanou et al. demonstrated that a cut-off of ≥20 EpCAM+ tdEVs/7.5 mL in blood from patients with different cancer types can predict OS, with a prognostic value equivalent to CTC enumeration [59]. This evidence concerns the gene EPCAM and cancer.